IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.
Yousefi H, Momeny M, Ghaffari SH, Parsanejad N, Poursheikhani A, Javadikooshesh S, Zarrinrad G, Esmaeili F, Alishahi Z, Sabourinejad Z, Sankanian G, Shamsaiegahkani S, Bashash D, Shahsavani N, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A.
Yousefi H, et al. Among authors: parsanejad n.
Tumori. 2019 Feb;105(1):84-91. doi: 10.1177/0300891618784790. Epub 2018 Jul 19.
Tumori. 2019.
PMID: 30021477